A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of Nintedanib vs. Sorafenib in European patients with advanced hepatocellular carcinoma

Daniel H Palmer, Yuk Ma, Markus Peck-Radosavljevic, Paul Ross, J Graham, L. Fartoux, A. Deptala, M. Studeny, D. Schnell, J. Hocke, A.-B. Loembe, T Meyer

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)
224 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of Nintedanib vs. Sorafenib in European patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences